发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 149 |
| Australia | 5 |
| England | 5 |
| Italy | 4 |
| Canada | 3 |
| CHINA MAINLAND | 2 |
| GERMANY (FED REP GER) | 2 |
| Japan | 2 |
| France | 1 |
| Greece | 1 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF TEXAS SYSTEM | 24 |
| MAYO CLINIC | 16 |
| CLEVELAND CLINIC FOUNDATION | 10 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 9 |
| CITY OF HOPE | 8 |
| HARVARD UNIVERSITY | 8 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 8 |
| COLUMBIA UNIVERSITY | 7 |
| UNIVERSITY OF PENNSYLVANIA | 7 |
| CORNELL UNIVERSITY | 6 |
文章引用情况
1
Frontline Therapy of CLL: Evolving Treatment Paradigm2
Update on the Treatment of Anaplastic Large Cell Lymphoma3
Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities4
Targeted Therapies in CLL: Monotherapy Versus Combination Approaches5
Is There a Role for Dose Modification of TKI Therapy in CML?6
Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper7
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors8
Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis9
Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold10
Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?